BOSTON (June 13, 2014) — David J. Dykeman, co-chair of Greenberg Traurig’s Global Life Sciences & Medical Technology Group and co-chair of the firm’s Intellectual Property (IP) Group in Boston, will speak at the World Academy of Science and Engineering Technology (WASET) International Conference on Managing Intellectual Property (ICMIP) on June 26 - 27, 2014 in Paris, France.
Dykeman will serve as Session II co-chair and will present his paper "Managing Patent Portfolios in the Era of Patent Reform and Patent Trolls" on Thursday, June 26, 2014. He will discuss creating and managing high-value patent portfolios including:
- Changes to US and European patent systems due to patent reform
- US Supreme Court’s issuance of far-reaching patent opinions, including the recent decisions: Mayo v. Prometheus Laboratories, Bilski v. Kappos, and Association for Molecular Pathology v. USPTO and Myriad Genetics
- Efforts to address patent troll litigation
A registered patent attorney with over 18 years of experience in patents, intellectual property, and licensing, Dykeman focuses his practice on securing strategic worldwide intellectual property protection and related business strategy for high-tech clients, with particular expertise in medical devices, life sciences, biotechnology and healthcare IT. Dykeman is the founding co-chair of the ABA Section of Science & Technology Law's Medical Device Committee, and serves on the Editorial Advisory Board of Medical Device + Diagnostic Industry (MD+DI) Magazine.
An author of over 45 articles and a speaker at over 40 conferences on medical devices and life sciences intellectual property, Dykeman was honored as one of “40 Medtech Innovators Under 40” by MD+DI Magazine, and was named one of the top 250 Patent and Technology Licensing Practitioners in the world by Intellectual Asset Management (IAM) Magazine.
About the ICMIP 2014: International Conference on Managing Intellectual Property
The ICMIP 2014: International Conference on Managing Intellectual Property aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results about all aspects of Managing Intellectual Property. It also provides the premier interdisciplinary forum for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the solutions adopted in the field of Managing Intellectual Property.
About Greenberg Traurig’s Life Sciences & Medical Technology Group
Greenberg Traurig’s Life Sciences & Medical Technology Group advises clients ranging from start-ups to large multinational public companies to leading research institutions. The group’s attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through product marketing.